{"DataElement":{"publicId":"14468327","version":"1","preferredName":"Patient Myelodysplastic Syndrome Diagnosis Genetic Abnormality Type","preferredDefinition":"A description of the genetic abnormalities present for myelodysplastic syndrome.","longName":"MDS_GEN_AB_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3544337","version":"1","preferredName":"Patient Myelodysplastic Syndrome Diagnosis","preferredDefinition":"information related to a person who has a scientific determination of clonal hematopoietic disorder, accompanied by an increase in myeloblasts as a result of exposure to alkylating agents and/or radiotherapy.","longName":"PT_MDS_DX","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497374","version":"1","preferredName":"MDS Diagnosis","preferredDefinition":"Myelodysplastic syndrome (MDS) is a clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines.  The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia.  MDS may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy.  (WHO, 2001) -- 2003:The process of identifying a disease by the signs and symptoms.","longName":"C3247:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome","conceptCode":"C3247","definition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1905DEFE-0A41-6098-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-20","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-20","modifiedBy":"ONEDATA","dateModified":"2006-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6644C27-54DF-2768-E040-BB89AD434536","latestVersionIndicator":"Yes","beginDate":"2012-08-03","endDate":null,"createdBy":"WONGW","dateCreated":"2012-08-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10401859","version":"1","preferredName":"Molecular Abnormality Type","preferredDefinition":"A molecular or cytogenic abnormality which occurs in either human disease states or disease models._Something distinguishable as an identifiable class based on common qualities.","longName":"10401859v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BCR-ABL1 t(9;22)(q34;q11.2)","valueDescription":null,"ValueMeaning":{"publicId":"10404266","version":"1","preferredName":"BCR-ABL1 t(9;22)(q34;q11.2)","longName":"10404266v1.00","preferredDefinition":"BCR-ABL1 t(9;22)(q34;q11.2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-31BA-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31BD-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"BCR-ABL1-like (Ph-like) ALL","valueDescription":null,"ValueMeaning":{"publicId":"10404267","version":"1","preferredName":"BCR-ABL1-like (Ph-like) ALL","longName":"10404267v1.00","preferredDefinition":"BCR-ABL1-like (Ph-like) ALL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-31BB-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31BE-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"KMT2A (MLL)","valueDescription":null,"ValueMeaning":{"publicId":"10404268","version":"1","preferredName":"KMT2A (MLL)","longName":"10404268v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the KMT2A (MLL) gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KMT2A Gene Rearrangement","conceptCode":"C122623","definition":"A molecular abnormality indicating rearrangement of the KMT2A (MLL) gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-31BC-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31BF-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"TCF3-HLF","valueDescription":null,"ValueMeaning":{"publicId":"10383309","version":"1","preferredName":"TCF3-HLF","longName":"10383309v1.00","preferredDefinition":"TCF3-HLF","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-9663-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31C0-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"CRLF2/JAK pathway abnormalities","valueDescription":null,"ValueMeaning":{"publicId":"10383310","version":"1","preferredName":"CRLF2/JAK pathway abnormalities","longName":"10383310v1.00","preferredDefinition":"CRLF2/JAK pathway abnormalities","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-9664-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31C1-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"tp53","valueDescription":null,"ValueMeaning":{"publicId":"10382635","version":"1","preferredName":"tp53","longName":"10382635v1.00","preferredDefinition":"A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-2318-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-27","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31C2-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"None","valueDescription":null,"ValueMeaning":{"publicId":"3030997","version":"1","preferredName":"None","longName":"3030997","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82DD865C-2FEA-9DF4-E040-BB89AD434EAA","latestVersionIndicator":"Yes","beginDate":"2010-03-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31C3-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFDCA1E9-31C4-2FB2-E053-731AD00A0138","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"BCR::ABL1","valueDescription":null,"ValueMeaning":{"publicId":"3935833","version":"1","preferredName":"BCR/ABL1 Fusion Gene","longName":"3935833","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-298C-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C95B-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"KMT2A","valueDescription":null,"ValueMeaning":{"publicId":"3370205","version":"1","preferredName":"KMT2A Gene","longName":"3370205","preferredDefinition":"This gene is involved in transcriptional regulation and alterations in the gene are associated with acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KMT2A Gene","conceptCode":"C18585","definition":"This gene is involved in transcriptional regulation and alterations in the gene are associated with acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8027DB7-73A0-2ADE-E040-BB89AD4305D8","latestVersionIndicator":"Yes","beginDate":"2012-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C95C-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"ZNF384","valueDescription":null,"ValueMeaning":{"publicId":"6143054","version":"1","preferredName":"ZNF384 Gene","longName":"6143054","preferredDefinition":"This gene is involved in both transcriptional regulation and DNA binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ZNF384 Gene","conceptCode":"C97882","definition":"This gene is involved in both transcriptional regulation and DNA binding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67DC1C52-6E4A-7FD3-E053-F662850A2405","latestVersionIndicator":"Yes","beginDate":"2018-03-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-20","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C95D-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"BCL11B","valueDescription":null,"ValueMeaning":{"publicId":"7546304","version":"1","preferredName":"BCL11B Gene","longName":"7546304","preferredDefinition":"This gene may play a role in tumor suppression, signaling and T cell development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL11B Gene","conceptCode":"C91855","definition":"This gene may play a role in tumor suppression, signaling and T cell development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8A64761-37FB-4A6E-E053-4EBD850A0B3A","latestVersionIndicator":"Yes","beginDate":"2021-01-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-11","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C95E-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"Monosomy 7 or del(7q)","valueDescription":null,"ValueMeaning":{"publicId":"6845818","version":"1","preferredName":"Loss of Chromosome 7","longName":"6845818","preferredDefinition":"A cytogenic abnormality that refers to loss of all or part of chromosome 7.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 7","conceptCode":"C36524","definition":"A cytogenetic abnormality that refers to loss of all or part of chromosome 7.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2CC8F4-453D-771D-E053-F662850A28D3","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C95F-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"Del(5q)","valueDescription":null,"ValueMeaning":{"publicId":"5606929","version":"1","preferredName":"Loss of Chromosome 5q","longName":"5606929","preferredDefinition":"A cytogenic abnormality that refers to loss of all or part of the long arm of chromosome 5 (5q). It is associated with the development of myelodysplastic syndrome with isolated deletion (5q), acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 5q","conceptCode":"C27712","definition":"A cytogenetic abnormality that refers to loss of all or part of the long arm of chromosome 5 (5q). It is associated with the development of myelodysplastic syndrome with isolated deletion (5q), acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43CD1E3A-934E-4862-E053-F662850AAA4C","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-12-16","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C960-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"PTPN11","valueDescription":null,"ValueMeaning":{"publicId":"6142267","version":"1","preferredName":"PTPN11 Gene","longName":"6142267","preferredDefinition":"This gene plays a role in the regulation of cell signaling. It is involved in cell migration, metabolic control, mitogenic activation and gene transcription.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PTPN11 Gene","conceptCode":"C26337","definition":"This gene plays a role in the regulation of cell signaling. It is involved in cell migration, metabolic control, mitogenic activation and gene transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67CD7196-6854-130D-E053-F662850A0236","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-19","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C961-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"KRAS","valueDescription":null,"ValueMeaning":{"publicId":"4233115","version":"1","preferredName":"KRAS Gene","longName":"4233115","preferredDefinition":"This gene is involved in signal transduction and apoptosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Gene","conceptCode":"C25785","definition":"This gene is involved in signal transduction and apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4F7B19C-C74A-BB5D-E040-BB89AD4325AD","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-19","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C962-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"NRAS","valueDescription":null,"ValueMeaning":{"publicId":"4233114","version":"1","preferredName":"NRAS Gene","longName":"4233114","preferredDefinition":"This gene plays a role in signal transduction and cell cycle regulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRAS Gene","conceptCode":"C25786","definition":"This gene plays a role in signal transduction and cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4F7B19C-C727-BB5D-E040-BB89AD4325AD","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-19","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C963-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"NF1","valueDescription":null,"ValueMeaning":{"publicId":"3425296","version":"1","preferredName":"NF1 Gene","longName":"3425296","preferredDefinition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene","conceptCode":"C17424","definition":"This gene plays a role in signal transduction and cytoskeletal remodeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC61C31B-42E9-4F48-E040-BB89AD434E83","latestVersionIndicator":"Yes","beginDate":"2012-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C94E51-C964-7289-E063-731AD00AEC3E","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"CBL","valueDescription":null,"ValueMeaning":{"publicId":"4233116","version":"1","preferredName":"CBL Gene","longName":"4233116","preferredDefinition":"This gene plays a role in signal transduction and the regulation of protein degradation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CBL Gene","conceptCode":"C18364","definition":"This gene plays a role in signal transduction and the regulation of protein degradation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4F7B19C-C76F-BB5D-E040-BB89AD4325AD","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-19","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C951FA-A563-7347-E063-731AD00AD8F8","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"},{"value":"SETBP1","valueDescription":null,"ValueMeaning":{"publicId":"4566851","version":"1","preferredName":"SETBP1 Gene","longName":"4566851","preferredDefinition":"This gene may be involved in the modulation of protein SET activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SETBP1 Gene","conceptCode":"C106635","definition":"This gene may be involved in the modulation of protein SET activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A53763-E5CC-F1C0-E050-BB89AD43225F","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-10-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04C951FA-A564-7347-E063-731AD00AD8F8","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5946071","version":"1","preferredName":"Molecular Abnormality Type","preferredDefinition":"A molecular or cytogenic abnormality which occurs in either human disease states or disease models.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3910:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57F8F28F-67EB-1DD3-E053-F662850A4FC7","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-30","modifiedBy":"ONEDATA","dateModified":"2017-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-31B9-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":"2023.9.7 PVs added per ticket request CADSR0002816. ak 9/7/22 Released VD per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the genetic abnormalities present for myelodysplastic syndrome?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Myelodysplastic syndrome with known defining genetic abnormality:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"04CA3768-6B6D-28EB-E063-731AD00AE115","latestVersionIndicator":"Yes","beginDate":"2023-09-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-07","modifiedBy":"KUMMEROA","dateModified":"2023-10-26","changeDescription":null,"administrativeNotes":"2023.10.26 Released. ak2023.9.7 Created per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"}}